Icosavax rallies $100m Series B
Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing.
Icosavax, a developer of vaccines against infection diseases, has raised $100 million in Series B Financing.
Copyright PEI Media
Not for publication, email or dissemination